Conglomerates
Compare Stocks
4 / 10Stock Comparison
HON vs XOM vs CVX vs MMM
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Conglomerates
HON vs XOM vs CVX vs MMM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Conglomerates | Oil & Gas Integrated | Oil & Gas Integrated | Conglomerates |
| Market Cap | $136.91B | $620.85B | $364.18B | $74.98B |
| Revenue (TTM) | $36.76B | $323.90B | $184.43B | $25.02B |
| Net Income (TTM) | $4.10B | $28.84B | $12.30B | $2.79B |
| Gross Margin | 36.9% | 21.7% | 30.4% | 39.5% |
| Operating Margin | 14.9% | 10.5% | 9.0% | 19.6% |
| Forward P/E | 20.5x | 14.8x | 15.0x | 16.6x |
| Total Debt | $34.58B | $43.54B | $46.74B | $12.94B |
| Cash & Equiv. | $12.49B | $10.68B | $6.47B | $5.24B |
HON vs XOM vs CVX vs MMM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| 3M Company (MMM) | 100 | 109.9 | +9.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HON vs XOM vs CVX vs MMM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HON carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Rev growth 7.8%, EPS growth -15.5%, 3Y rev CAGR 1.8%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
XOM is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (14.8x vs 16.6x)
- +43.9% vs HON's +2.8%
CVX is the clearest fit if your priority is long-term compounding.
- 135.8% 10Y total return vs XOM's 105.0%
- 3.8% yield, 8-year raise streak, vs XOM's 2.7%
MMM is the clearest fit if your priority is efficiency.
- 7.5% ROA vs CVX's 4.2%, ROIC 28.1% vs 6.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.8% revenue growth vs CVX's -4.6% | |
| Value | Lower P/E (14.8x vs 16.6x) | |
| Quality / Margins | 11.2% margin vs CVX's 6.7% | |
| Stability / Safety | Beta 0.74 vs MMM's 1.06, lower leverage | |
| Dividends | 3.8% yield, 8-year raise streak, vs XOM's 2.7% | |
| Momentum (1Y) | +43.9% vs HON's +2.8% | |
| Efficiency (ROA) | 7.5% ROA vs CVX's 4.2%, ROIC 28.1% vs 6.2% |
HON vs XOM vs CVX vs MMM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HON vs XOM vs CVX vs MMM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MMM leads in 2 of 6 categories
XOM leads 1 • HON leads 0 • CVX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MMM leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 12.9x MMM's $25.0B. Profitability is closely matched — net margins range from 11.2% (HON) to 6.7% (CVX). On growth, MMM holds the edge at +1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $36.8B | $323.9B | $184.4B | $25.0B |
| EBITDAEarnings before interest/tax | $6.5B | $59.9B | $37.1B | $5.2B |
| Net IncomeAfter-tax profit | $4.1B | $28.8B | $12.3B | $2.8B |
| Free Cash FlowCash after capex | $4.2B | $23.6B | $16.2B | $2.1B |
| Gross MarginGross profit ÷ Revenue | +36.9% | +21.7% | +30.4% | +39.5% |
| Operating MarginEBIT ÷ Revenue | +14.9% | +10.5% | +9.0% | +19.6% |
| Net MarginNet income ÷ Revenue | +11.2% | +8.9% | +6.7% | +11.1% |
| FCF MarginFCF ÷ Revenue | +11.4% | +7.3% | +8.8% | +8.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.9% | -1.3% | -5.3% | +1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -41.9% | -11.0% | -24.5% | -39.7% |
Valuation Metrics
Evenly matched — XOM and CVX each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, XOM trades at a 26% valuation discount to HON's 29.4x P/E. On an enterprise value basis, CVX's 10.9x EV/EBITDA is more attractive than HON's 20.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $136.9B | $620.8B | $364.2B | $75.0B |
| Enterprise ValueMkt cap + debt − cash | $159.0B | $653.7B | $404.5B | $82.7B |
| Trailing P/EPrice ÷ TTM EPS | 29.36x | 21.86x | 27.53x | 23.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.52x | 14.79x | 15.02x | 16.55x |
| PEG RatioP/E ÷ EPS growth rate | 15.99x | — | — | — |
| EV / EBITDAEnterprise value multiple | 19.99x | 10.91x | 10.89x | 15.20x |
| Price / SalesMarket cap ÷ Revenue | 3.66x | 1.92x | 1.97x | 3.01x |
| Price / BookPrice ÷ Book value/share | 9.00x | 2.37x | 1.76x | 16.32x |
| Price / FCFMarket cap ÷ FCF | 25.39x | 26.29x | 21.95x | 53.71x |
Profitability & Efficiency
MMM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MMM delivers a 65.3% return on equity — every $100 of shareholder capital generates $65 in annual profit, vs $7 for CVX. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMM's 2.73x. On the Piotroski fundamental quality scale (0–9), HON scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +23.1% | +10.7% | +7.2% | +65.3% |
| ROA (TTM)Return on assets | +5.3% | +6.4% | +4.2% | +7.5% |
| ROICReturn on invested capital | +12.6% | +8.6% | +6.2% | +28.1% |
| ROCEReturn on capital employed | +12.6% | +8.9% | +6.6% | +16.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 5 | 5 |
| Debt / EquityFinancial leverage | 2.24x | 0.16x | 0.24x | 2.73x |
| Net DebtTotal debt minus cash | $22.1B | $32.9B | $40.3B | $7.7B |
| Cash & Equiv.Liquid assets | $12.5B | $10.7B | $6.5B | $5.2B |
| Total DebtShort + long-term debt | $34.6B | $43.5B | $46.7B | $12.9B |
| Interest CoverageEBIT ÷ Interest expense | 3.92x | 69.44x | 17.22x | 6.52x |
Total Returns (Dividends Reinvested)
XOM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,464 today (with dividends reinvested), compared to $9,690 for MMM. Over the past 12 months, XOM leads with a +43.9% total return vs HON's +2.8%. The 3-year compound annual growth rate (CAGR) favors MMM at 21.8% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.9% | +20.3% | +18.2% | -10.7% |
| 1-Year ReturnPast 12 months | +2.8% | +43.9% | +39.5% | +5.8% |
| 3-Year ReturnCumulative with dividends | +16.2% | +44.9% | +26.7% | +80.7% |
| 5-Year ReturnCumulative with dividends | +3.3% | +164.6% | +94.0% | -3.1% |
| 10-Year ReturnCumulative with dividends | +135.1% | +105.0% | +135.8% | +32.5% |
| CAGR (3Y)Annualised 3-year return | +5.1% | +13.2% | +8.2% | +21.8% |
Risk & Volatility
Evenly matched — HON and XOM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than MMM's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HON currently trades 87.1% from its 52-week high vs MMM's 81.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | -0.15x | -0.05x | 1.06x |
| 52-Week HighHighest price in past year | $248.18 | $176.41 | $214.71 | $177.41 |
| 52-Week LowLowest price in past year | $186.76 | $101.19 | $133.77 | $137.70 |
| % of 52W HighCurrent price vs 52-week peak | +87.1% | +83.0% | +85.0% | +81.0% |
| RSI (14)Momentum oscillator 0–100 | 45.1 | 42.4 | 42.1 | 48.8 |
| Avg Volume (50D)Average daily shares traded | 3.7M | 18.9M | 11.0M | 3.6M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HON as "Buy", XOM as "Hold", CVX as "Buy", MMM as "Hold". Consensus price targets imply 16.0% upside for MMM (target: $167) vs 4.6% for CVX (target: $191). For income investors, CVX offers the higher dividend yield at 3.76% vs MMM's 1.52%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $243.83 | $160.43 | $190.93 | $166.75 |
| # AnalystsCovering analysts | 28 | 55 | 53 | 33 |
| Dividend YieldAnnual dividend ÷ price | +2.1% | +2.7% | +3.8% | +1.5% |
| Dividend StreakConsecutive years of raises | 15 | 26 | 8 | 0 |
| Dividend / ShareAnnual DPS | $4.63 | $4.00 | $6.87 | $2.18 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.8% | +3.3% | +3.3% | +6.4% |
MMM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). XOM leads in 1 (Total Returns). 3 tied.
HON vs XOM vs CVX vs MMM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HON or XOM or CVX or MMM a better buy right now?
For growth investors, Honeywell International Inc.
(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). Exxon Mobil Corporation (XOM) offers the better valuation at 21. 9x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate Honeywell International Inc. (HON) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HON or XOM or CVX or MMM?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 21.
9x versus Honeywell International Inc. at 29. 4x. On forward P/E, Exxon Mobil Corporation is actually cheaper at 14. 8x.
03Which is the better long-term investment — HON or XOM or CVX or MMM?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +164.
6%, compared to -3. 1% for 3M Company (MMM). Over 10 years, the gap is even starker: CVX returned +135. 8% versus MMM's +32. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HON or XOM or CVX or MMM?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus 3M Company's 1. 06β — meaning MMM is approximately -824% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 3% for 3M Company — giving it more financial flexibility in a downturn.
05Which is growing faster — HON or XOM or CVX or MMM?
By revenue growth (latest reported year), Honeywell International Inc.
(HON) is pulling ahead at 7. 8% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: Exxon Mobil Corporation grew EPS -14. 5% year-over-year, compared to -31. 8% for Chevron Corporation. Over a 3-year CAGR, HON leads at 1. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HON or XOM or CVX or MMM?
3M Company (MMM) is the more profitable company, earning 13.
0% net margin versus 6. 7% for Chevron Corporation — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMM leads at 18. 3% versus 9. 0% for CVX. At the gross margin level — before operating expenses — MMM leads at 39. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HON or XOM or CVX or MMM more undervalued right now?
On forward earnings alone, Exxon Mobil Corporation (XOM) trades at 14.
8x forward P/E versus 20. 5x for Honeywell International Inc. — 5. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMM: 16. 0% to $166. 75.
08Which pays a better dividend — HON or XOM or CVX or MMM?
All stocks in this comparison pay dividends.
Chevron Corporation (CVX) offers the highest yield at 3. 8%, versus 1. 5% for 3M Company (MMM).
09Is HON or XOM or CVX or MMM better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Both have compounded well over 10 years (XOM: +105. 0%, MMM: +32. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HON and XOM and CVX and MMM?
These companies operate in different sectors (HON (Industrials) and XOM (Energy) and CVX (Energy) and MMM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HON is a mid-cap quality compounder stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; MMM is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.